Public Advisory Panel Accepts FDA’s Class II Re-Classification Suggestion FREDERICK, Md., May 23, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of very effective, safe consumer medical devices, comments on the FDA panel meeting for non-thermal shortwave diathermy: The FDA’s Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was held on May 21, […]
View PostBioElectronics Adds Venezuela to its RecoveryRx™ Distribution Network
FREDERICK, Md., April 9, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has established a Venezuelan distributor for its ActiPatch® Pain Relief Therapy and RecoveryRx™ Postoperative and Wound Care Recovery medical devices that provide labor free, 24-hour therapy […]
View PostBioElectronics Obtains Additional US Patent For Its Unique Pain Devices
FREDERICK, Md., April 1, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics, announced today that the Company has received notice from the United States Patent and Trademark Office that patent number 8,412,328 is being issued. This new US patent, our 5 other US patents, and 2 pending provide us sound intellectual […]
View PostBioElectronics Announces RecoveryRx™ Product Distribution in Ireland
FREDERICK, Md., March 21, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has begun distribution in Ireland of its RecoveryRx™ product line with O’Neill Healthcare (www.onhealthcare.ie). RecoveryRx™ (www.recoveryrx.co) medical devices provide labor free, 24-hour therapy to reduce pain, […]
View PostBioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
FREDERICK, Md., March 19, 2013 /PRNewswire/ – BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, technological solutions for chronic and post-operative wound care, announced today that it has begun distribution in Italy of its RecoveryRx™ product line with Biomax Spa (www.biomax.it). RecoveryRx™ (www.recoveryrx.co) medical devices provide labor free, 24-hour therapy to reduce pain, […]
View PostBioElectronics Expands Clinical Research – Three New Clinical Studies
FREDERICK, Md., Feb. 28, 2013 /PRNewswire/ — BioElectronics Corporation (OTC PINK: BIEL), the maker of consumer medical devices for pain and healing, announces the initiation of a series of new clinical trials. Hernia Study: Dr. Frederik Berrevoetk , Current President of the Belgian Section of Abdominal Wall Surgery at the University Hospital Ghent, Belgium is […]
View PostBioElectronics Announces Publication of Patent Application – RF Induced Thermal Treatment of Tissue Pain
FREDERICK, Md., Feb. 26, 2013 /PRNewswire/ — BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices, announced today that the World Intellectual Property Organization has published the International Patent Application for RF Induced Thermal Treatment of Tissue Pain. While pulsed shortwave therapy is an established medical therapy, this patent […]
View PostBioElectronics’ Study on Postoperative Pain Reduction Published in the Aesthetic Plastic Surgery Journal
BioElectronics’ Study on Postoperative Pain Reduction Published in the Aesthetic Plastic Surgery Journal FREDERICK, MD–(Marketwire – Nov 3, 2011) – BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced the publication of an article in the peer reviewed journal Aesthetic Plastic Surgery that demonstrates the effective use […]
View PostBioElectronics Appoints a Director of Clinical Research
FREDERICK, MD–(Marketwire – Nov 29, 2011) – BioElectronics Corporation (OTCQB: BIEL) (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, is pleased to announce the appointment of Ian Rawe, Ph.D. as its Director of Clinical Research.Dr. Rawe obtained a Ph.D. in Biophysics from the Open University, Oxford UK studying wound healing and scar […]
View Post- 1
- 2